Meta (META) Instagram head Adam Mosseri expected to testify in states' trial today, says California AG’s office
Newsquawk Staff ·
Meta (META) Instagram head Adam Mosseri expected to testify in states' trial today, says California AG’s office.
What it means
The multi-state litigation against Meta over alleged harm to minors is the broadest coordinated legal action the company has faced, and executive testimony of this kind sits at the stage where the proceedings shift from filings to on-record fact-finding. A senior product head appearing in person matters less for any single admission than for what it signals about the trial's progression and the internal documents likely to be aired around it. In comparable episodes, equity reaction to testimony days has tended to be contained unless testimony produces genuinely new disclosures; the larger repricing events in platform regulation cases have historically clustered around rulings, settlements, and remedy phases rather than individual witness appearances. The structural read is that state AG coalitions of this size have typically ended in negotiated settlements with monetary and behavioural terms rather than break-up outcomes, which caps the tail while leaving a long litigation overhang on the name. Worth noting is the distinction between this case and federal antitrust actions, since the states' theory rests on consumer protection and child safety rather than competition, carrying different remedy channels. Follow-ons include further executive and expert testimony and any parallel movement in the federal and congressional tracks on platform liability.
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- Meta's (META) Muse AI to counter China models with subscribers, not ads, Nikkei reports
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation
Related headlines
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post13 hours ago
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans14 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS16 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system17 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)18 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed18 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce19 hours ago
- Daily US Equity Opening News - SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at USD 1.25tln valuation; AAPL foldable iPhone launches; SKHY cancels Solidigm Nasdaq IPO plans; WDC beat and raise1 day ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease13 hours ago
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL15 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 202716 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability17 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer19 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM20 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years21 hours ago